The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis

Rheumatology International

Volumn 31, Issue 3, 2011, Pages 315-319

  Ryu, Hee Jung ^a   Takeuchi, Fujio ^c   Kuwata, Shoji ^b   Kim, Yoon Jun ^a   Lee, Eun Young ^a   Lee, Eun Bong ^a   Song, Yeong Wook ^a  

^a Seoul National University   (South Korea)

^b TEIKYO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti agalactosyl IgG antibody; Anti cyclic citrullinated peptide antibody; Chronic viral hepatitis; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AGALACTOSYL IMMUNOGLOBULIN G ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNONEPHELOMETRY; MAJOR CLINICAL STUDY; MYOSITIS; NEPHELOMETRY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULIN G; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; ROC CURVE; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 79954439539     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1260-5     Document Type: Article

References (29)

1. DM Lee ME Weinblatt 2001 Rheumatoid arthritis Lancet 358 903 911 1:CAS:528:DC%2BD3MXmvVKmtr8%3D 10.1016/S0140-6736(01)06075-5 11567728 (Pubitemid 32900579)
2. LR Lard H Visser I Speyer IE vander Horst-Bruinsma AH Zwinderman FC Breedveld, et al. 2001 Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies Am J Med 111 446 451 1:CAS:528: DC%2BD3MXnvFCqsrk%3D 10.1016/S0002-9343(01)00872-5 11690569 (Pubitemid 33016415)
3. MA Bukhari NJ Wiles M Lunt BJ Harrison DG Scott DP Symmons, et al. 2003 Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study Arthritis Rheum 48 46 53 1:STN:280:DC%2BD3s%2FitVagsA%3D%3D 10.1002/art.10727 12528102 (Pubitemid 36091646)
4. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 10.1002/art.1780310302 3358796 (Pubitemid 18091653)
5. Smolen JS (1996) Autoantibodies in rheumatoid arthritis. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of disease. Kluwer Academic Publishers, Dordrecht C1. 1/1-18
6. M Wagatsuma M Kimura R Suzuki F Takeuchi K Matsuta H Watanabe 1996 Ezrin, radoxin and moesin are possible autoimmune antigens in rheumatoid arthritis Mol Immunol 33 1171 1176 1:CAS:528:DyaK2sXitVyhtLg%3D 10.1016/S0161-5890(96)00083-1 9070665 (Pubitemid 27105325)
7. GA Schellekens H Visser BA de Jong FH van den Hoogen JM Hazes FC Breedveld WJ van Venrooij 2000 The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum 43 155 163 1:CAS:528:DC%2BD3cXns1ygtg%3D%3D 10.1002/1529-0131(200001)43:1<155::AID- ANR20>3.0.CO;2-3 10643712 (Pubitemid 30368225)
8. H Visser S le Cessie K Vos FC Breedveld JM Hazes 2002 How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis Arthritis Rheum 46 357 365 10.1002/art.10117 11840437 (Pubitemid 34136572)
9. DM Lee PH Schur 2003 Clinical utility of the anti-CCP assay in patients with rheumatic diseases Ann Rheum Dis 62 870 874 1:CAS:528:DC%2BD3sXns1Sisbs%3D 10.1136/ard.62.9.870 12922961 (Pubitemid 37026499)
10. S Bas TV Perneger M Seitz JM Tiercy P roux-Lombard PA Guerne 2002 Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors Rheumatology (Oxford) 41 809 814 1:CAS:528:DC%2BD38Xmt1Ohs7k%3D 10.1093/rheumatology/41.7.809 (Pubitemid 34822965)
11. O Vittecoq B Incaurgarat F Jouen-Beades J Legoedec O Letourneur D Rolland, et al. 2004 Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis Clin Exp Immunol 135 173 180 1:CAS:528:DC%2BD2cXnslGjtA%3D%3D 10.1111/j.1365-2249.2004.02341.x 14678280 (Pubitemid 38067943)
12. D Sène P Ghillani-Dalbin N Limal V Thibault T van Boekel JC Piette P Cacoub 2006 Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome Ann Rheum Dis 65 3 394 397 10.1136/ard.2005.038042 16474032 (Pubitemid 43268232)
13. T Mizuochi 1994 Significance of measurement of rheumatoid factor oligosaccharide for early rheumatoid arthritis Rheumati Ka 12 337 343
14. T Wei A Matsumoto K Shikata F Takeuchi T Konishi M Nakata T Mizuochi 1998 Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis Glycoconj J 15 929 934 10.1023/A:1006971318736 (Pubitemid 29054442)
15. A Matsumoto K Shikata F Takeuchi N Kojima T Mizuochi 2000 Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation J Biochem 128 621 628 1:CAS:528: DC%2BD3cXosFOjsrc%3D 11011144
16. AJ Soltys FC Hay A Bond JS Axford MG Jones I Randen KM Thompson JB Natvig 1994 The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content Scand J Immunol 40 135 143 1:CAS:528:DyaK2cXmt1ygtrs%3D 10.1111/j.1365-3083.1994.tb03442.x 8047835 (Pubitemid 24251729)
17. K Higami M Hakoda S Kotake 1997 Evaluation of qualitative diagnostic kit (p-155) for detection of anti-agalactosyl IgG antibodies Rheumati Ka 18 515 520
18. I Ezaki M Shingu E Furuta 1996 Clinical significance of anti-agalactosyl IG antibodies in early rheumatoid arthritis Kiso Rhinsho 30 3599 3606
19. C Nishijima S Sato K Takehara 2001 Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis J Rheumatol 28 1847 1851 1:STN:280:DC%2BD3Mvmtlahsw%3D%3D 11508588 (Pubitemid 32726932)
20. MC Lu SC Hsieh NS Lai KJ Li CH Wu CL Yu 2007 Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics Clin Exp Rheumatol 25 716 721 18078619
21. Y Ichikawa C Yamada T Horiki Y Hoshina M Uchiyama Y Yamada J Toumatu 1998 Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis Clin Exp Rheumatol 16 709 715 1:STN:280:DyaK1M%2FmtVOmtg%3D%3D 9844764
22. Y Mimura H Ihn M Jinnin Y Asano K Yamane N Yazawa K Tamaki 2004 Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis Br J Dermatol 151 803 808 1:CAS:528:DC%2BD2cXhtVKitrrO 10.1111/j.1365-2133.2004.06195.x 15491420 (Pubitemid 39482113)
23. DK Christodoulou GN Dalekos MH Merkouropoulos KG Kistis G Georgitsi E Zervou K Zachou EV Tsianos 2001 Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice Eur J Intern Med 12 435 441 10.1016/S0953-6205(01)00151-0 11557330 (Pubitemid 32823523)
24. BD Clifford D Donahue L Smith E Cable B Luttig M Manns HL Bonkovsky 1995 High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C Hepatology 21 613 619 1:STN:280:DyaK2M7otVyitA%3D%3D 7533120
25. SI Lee WH Yoo HJ Yun DS Kim HS Lee SI Choi JA Hur YG Cho 2007 Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection Clin Rheumatol 26 1079 1082 10.1007/s10067-006-0451-7 17136313 (Pubitemid 46863948)
26. T Koga K Migita T Miyashita Y Maeda M Nakamura S Abiru M Myoji A Komori K Yano H Yatsuhashi K Eguchi H Ishibashi 2008 Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases Clin Exp Rheumatol 26 121 124 1:STN:280:DC%2BD1c7ntVegug%3D%3D 18328158 (Pubitemid 351385265)
27. FC Liu YC Chao TY Hou HC Chen RY Shyu TY Hsieh CH Chen DM Chang JH Lai 2008 Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia Clin Rheumatol 27 463 467 10.1007/s10067-007-0729-4 17876647 (Pubitemid 351404301)
28. M Bombardieri C Alessandri G Labbadia C Iannuccelli F Carlucci V Riccieri V Paoletti G Valesini 2004 Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement Arthritis Res Ther 6 R137 R141 1:CAS:528:DC%2BD2cXjvFGju7k%3D 10.1186/ar1041 15059277
29. MH Wener K Hutchinson C Morishima DR Gretch 2004 Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia Arthritis Rheum 50 2305 2308 1:CAS:528: DC%2BD2cXmsVantr0%3D 10.1002/art.20355 15248231 (Pubitemid 38924410)